4-羟基丁酰肼，CAS 登记号 3879-08-1，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 4-羟基丁酰肼 的 CAS 号：3879-08-1，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
4-Hydroxybutyric acid hydrazide · CAS 3879-08-1 · C4H10N2O2.
| CAS Registry Number | 3879-08-1 |
|---|---|
| PubChem CID | 220659 |
| Molecular formula | C4H10N2O2 |
| IUPAC name | 4-hydroxybutanehydrazide |
| Molecular Weight | 118.13 |
|---|---|
| XLogP3 | -1.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 118.074227566 |
| Monoisotopic Mass | 118.074227566 |
| Topological Polar Surface Area | 75.4 |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Reported hazard statements | H302, H312, H332 (16.7%), H315 (100%), H319 (100%), H335 (100%) |
|---|
H302+H312+H332 (16.7%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]
H302 (16.7%): Harmful if swallowed [Warning Acute toxicity, oral]
4-Hydroxybutyric Acid Hydrazide; RefChem:524021; 670-391-6; 4-hydroxybutanehydrazide; 3879-08-1; 4-hydroxybutanohydrazide; Butanoic acid, 4-hydroxy-, hydrazide; 4-hydroxybutanoic acid hydrazide; MFCD00051702; 4-???butan-1-ol; NSC3679; 4-hydroxybutyrohydrazide; 4-Hydroxybutanoic hydrazide; 4-Hydroxybutanoyl hydrazine; Oprea1_723416; AKOS MSC-0744
CAS 3879-08-1; molecular formula C4H10N2O2; molecular weight — g/mol.
4-Hydroxybutyric Acid Hydrazide, RefChem:524021, 670-391-6, 4-hydroxybutanehydrazide, 3879-08-1, 4-hydroxybutanohydrazide.
Hazard statements reported: H302, H312, H332, H315, H319.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.